Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Walsh

Showing results (631-640 of 706) with videos related to

Pageof 71
Sort By:
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|April 12, 2008
Potential of information technology in dental educationN Mattheos, N Stefanovic, P Apse, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2024
Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young AdultsAnirban Das, Suzanne P MacFarland, Julia Meade, et al.
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
Human Mutation|August 25, 2019
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaLiying Zhang, Michael F Walsh, Sowmya Jairam, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic MalignancyLuke D Maese, Marcin W Wlodarski, Sun Young Kim, et al.
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonistsChristina B Madsen-Duggan, John S Debenham, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonistsJohn S Debenham, Christina B Madsen-Duggan, Thomas F Walsh, et al.
Pageof 71

Showing results (631-640 of 706) with videos related to

Sort By:
Pageof 71
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|April 12, 2008
Potential of information technology in dental educationN Mattheos, N Stefanovic, P Apse, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2024
Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young AdultsAnirban Das, Suzanne P MacFarland, Julia Meade, et al.
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
Human Mutation|August 25, 2019
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaLiying Zhang, Michael F Walsh, Sowmya Jairam, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic MalignancyLuke D Maese, Marcin W Wlodarski, Sun Young Kim, et al.
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonistsChristina B Madsen-Duggan, John S Debenham, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonistsJohn S Debenham, Christina B Madsen-Duggan, Thomas F Walsh, et al.
Pageof 71